title: Stem cell-based bone repair.
abstract: To accelerate bone repair, one strategy is to deliver the cells that make bone. The current review focuses on stem cell-based bone repair. Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) can self-renew unlimitedly and differentiate into the bone forming cells - osteoblasts. Scientists have been actively investigating culture conditions to stably and efficiently induce differentiation of these stem cells into osteoblasts. However, ESCs have the issues of ethnics, immune response and both ESCs and iPSCs have tumorigenic potential. In contrast, bone marrow stromal/stem cells (BMSCs) hold great potential to enhance bone formation. Use of BMSCs can avoid the ethical issues and can obviate the immune response problem. However, BMSCs are a rare population with limited self-renewal ability and their differentiation ability decreases in elderly individuals. Considering the unlimited self-renewal ability, it is promising to develop protocols to differentiate ESCs into osteoblasts faithfully and efficiently. It is important to eliminate undifferentiated ESCs or iPSCs because of their tumorigenic potential. Therefore, future studies need to identify BMSCs specific cell surface markers since the cell surface markers utilized currently are not specific to BMSCs. Future studies also need to enhance the osteogenic potential without using viral vectors for transgene delivery to eliminate the risk of tumor generation.
authors.affiliation: Department of Medicine, University of Connecticut Health Center; University of Connecticut Stem Cell Institute 263 Farmington Ave., Farmington, CT 06030, USA.
authors.forename: Yurong
authors.initials: Y
authors.lastname: Fei
authors.forename: Ren-He
authors.initials: RH
authors.lastname: Xu
authors.forename: Marja M
authors.initials: MM
authors.lastname: Hurley
keywords: Bone repair; and bone marrow stromal/stem cells; embryonic stem cells